Indication

Dyschromia

Dyschromia refers to any abnormal alteration or irregularity in the pigmentation of the skin, hair, or nails, primarily affecting the integumentary system. Read more about Dyschromia

32 drugs 15 manufacturers

Advertisement

Drugs that treat it

Common Dyschromia therapies.

Showing 28–32 of 32 drugs

Filter & compare in the drug finder →Opens the drug finder with Dyschromia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Dyschromia.

Dyschromia refers to any abnormal alteration or irregularity in the pigmentation of the skin, hair, or nails, primarily affecting the integumentary system.

It encompasses hyperpigmentation, hypopigmentation, complete depigmentation, or mottled patterns characterized by concurrent hyper- and hypopigmented macules.

Pathophysiologically, the condition arises from disturbances in melanocyte density, melanin synthesis, or melanosome transfer, which may be triggered by ultraviolet radiation, hormonal fluctuations, cutaneous inflammation, genetic anomalies, or exogenous chemical exposures.

Although dyschromia can manifest across all demographic groups, it is especially common, prominent, and persistent in individuals with darker skin phototypes.

Personalize your experience

Follow Dyschromia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it